Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Current Taxes: 2024

Historic Current Taxes for Axsome Therapeutics (AXSM) over the last 1 years, with Dec 2024 value amounting to $960,000.

  • Axsome Therapeutics' Current Taxes rose 95.12% to $960,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $960,000, marking a year-over-year increase of 95.12%. This contributed to the annual value of $960,000 for FY2024, which is N/A change from last year.
  • Axsome Therapeutics' Current Taxes amounted to $960,000 in FY2024.
  • Axsome Therapeutics' Current Taxes' 5-year high stood at $960,000 during FY2024, with a 5-year trough of $960,000 in FY2024.
  • Over the past 1 years, Axsome Therapeutics' median Current Taxes value was $960,000 (recorded in 2024), while the average stood at $960,000.